| Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes Y Li, H Hu, Y Zheng, WT Donahoo, Y Guo, J Xu, WH Chen, N Liu, ... International journal of environmental research and public health 20 (5), 4036, 2023 | 5 | 2023 |
| Estimation of right atrial pressure using a portable handheld ultrasound device M Elzeneini, S Gupta, Y Li, Y Guo, R Hamburger The American Journal of Medicine 135 (11), 1378-1381, 2022 | 4 | 2022 |
| Palliative care utilization and trends among patients with metastatic breast cancer: A SEER-Medicare analysis. F Giap, YR Hong, Z Xie, Y Li, Y Guo, JA Bradley, OT Oladeru Journal of Clinical Oncology 40 (28_suppl), 75-75, 2022 | 2 | 2022 |
| Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes WH Chen, Y Li, L Yang, JM Allen, H Shao, WT Donahoo, L Billelo, X Hu, ... Plos one 19 (1), e0297208, 2024 | 1 | 2024 |
| County-Level Social Vulnerability si Associated With Higher Rates of Vascular Amputations in Florida KB Shah, M Elzeneini, S Shah, A Strong, Y Li, J Aranda, DE Winchester, ... Circulation 146 (Suppl_1), A11498-A11498, 2022 | 1 | 2022 |
| Dementia is associated with worse procedural outcomes after mitral valve transcatheter edge-to-edge repair M Elzeneini, AT Nassereddin, Y Li, SK Shah, D Winchester, A Li, Y Guo, ... Cardiovascular Revascularization Medicine, 2024 | | 2024 |
| Social Vulnerability Is Associated With Higher Rates of Hospitalizations and Amputations for Peripheral Arterial Disease KB Shah, M Elzeneini, SK Shah, AE Strong, Y Li, J Aranda, D Winchester, ... American Journal of Cardiology 203, 463-465, 2023 | | 2023 |
| 357-OR: Continuous Glucose Monitoring in Diabetes Patients with Cognitive Impairment P KOTECHA, WEIHAN CHEN, Y LI, WT DONAHOO, J BIAN, J GUO Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 881-P: Heterogenous Effects of SGLT2 Inhibitors on Nephrolithiasis in Older Adults with Type 2 Diabetes Y LI, HUI SHAO, YI GUO, Y ZHANG, V FONSECA, L SHI, J BIAN, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 880-P: Effects of Sodium–Glucose Cotransporter-2 Inhibitors on the Risk of Atrial Fibrillation in Older Adults with Type 2 Diabetes Y LI, YI GUO, S KIMMEL, J BIAN, D SCHATZ, J GUO Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Evaluating access to brentuximab in elderly patients with Hodgkin lymphoma. EM Mobley, Y Li, Y Guo, D Braithwaite, JR Wingard, R Mailhot Vega Journal of Clinical Oncology 41 (16_suppl), e18663-e18663, 2023 | | 2023 |
| Intravenous Iron Sucrose In Decompensated Heart Failure: A Safety Analysis Z Johnson, M Murray, L Meece, M Al-Ani, A Parker, J Vilaro, J Aranda, ... Journal of Cardiac Failure 29 (4), 678, 2023 | | 2023 |
| Differences in heart failure hospitalization risk following initiating SGLT2 inhibitors versus DPP4 inhibitors across race/ethnicity and rural/urban areas SJ Guo, Y Li, J Bian, DT Lackland, S Kimmel, DA Schatz, A Winterstein PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 196-196, 2022 | | 2022 |
| Geographic variation and racial disparities in novel glucose-lowering drugs adoption among US medicare beneficiaries with type 2 diabetes WH Chen, Y Li, JM Allen, H Shao, WT Donahoo, S Smith, SJ Guo PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 90-90, 2022 | | 2022 |
| 861-P: Differences in Heart Failure Hospitalization Risk following Initiating SGLT2 Inhibitors vs. DPP4 Inhibitors across Race/Ethnicity and Rural/Urban Areas J Guo, Y Li, J Bian, DT Lackland, S Kimmel, D Schatz, AG Winterstein Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 1107-P: Trends of First-Line Antidiabetic Treatment among 2007-2017 Medicare Beneficiaries Newly Diagnosed with Type 2 Diabetes (T2D) and Their Determinants Y LI, I HERNANDEZ, N GABRIEL, SL KANE-GILL, U ESSIEN, F TOLEDO, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| 314-OR: Racial/Ethnic and Geographic Variation in the Initiation of Antidiabetic Therapies in Medicare Enrollees with Newly Diagnosed Type 2 Diabetes (T2D) Y Li, J Guo, N Gabriel, SL Kane-Gill, U Essien, F Toledo, I Hernandez Diabetes 70 (Supplement_1), 2021 | | 2021 |
| Factors Associated with Initiation of Glucose-lowering Agents among Medicare Beneficiaries with Newly Diagnosed Type 2 Diabetes, 2007–2017 Y Li University of Pittsburgh, 2021 | | 2021 |
